AU2002309180A1 - Composition and kit for the treatment of inflammatory bowel diseases - Google Patents
Composition and kit for the treatment of inflammatory bowel diseasesInfo
- Publication number
- AU2002309180A1 AU2002309180A1 AU2002309180A AU2002309180A AU2002309180A1 AU 2002309180 A1 AU2002309180 A1 AU 2002309180A1 AU 2002309180 A AU2002309180 A AU 2002309180A AU 2002309180 A AU2002309180 A AU 2002309180A AU 2002309180 A1 AU2002309180 A1 AU 2002309180A1
- Authority
- AU
- Australia
- Prior art keywords
- kit
- treatment
- composition
- inflammatory bowel
- bowel diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
- A61K31/75—Polymers of hydrocarbons of ethene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2002/002275 WO2003090763A1 (en) | 2002-04-24 | 2002-04-24 | Composition and kit for the treatment of inflammatory bowel diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002309180A1 true AU2002309180A1 (en) | 2003-11-10 |
Family
ID=29266746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002309180A Abandoned AU2002309180A1 (en) | 2002-04-24 | 2002-04-24 | Composition and kit for the treatment of inflammatory bowel diseases |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1539192A1 (en) |
CN (1) | CN1627948A (en) |
AU (1) | AU2002309180A1 (en) |
WO (1) | WO2003090763A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4856948B2 (en) | 2005-12-27 | 2012-01-18 | コニカミノルタビジネステクノロジーズ株式会社 | Toner for electrostatic image development |
ES2405314T3 (en) | 2008-05-13 | 2013-05-30 | Apharm S.R.L. | Compositions and oral use of glycosaminoglycans |
US9241953B2 (en) | 2008-05-13 | 2016-01-26 | Apharm S.R.L. | Glycosaminoglycan oral use and compositions |
US8906883B2 (en) | 2009-06-10 | 2014-12-09 | Exthera Ab | Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate |
ITMI20131467A1 (en) | 2013-09-06 | 2015-03-07 | Sofar Spa | USE OF A COMPOSITION INCLUDING MICRO-ORGANISMS TO INCREASE THE INTESTINAL PRODUCTION OF BUTIRRIC ACID, FOLIC ACID OR NIACINE ACID AND / OR TO REDUCE THE INTESTINAL PRODUCTION OF SUCCINIC ACID |
MA39710A (en) | 2014-04-23 | 2015-10-29 | Sofar Spa | Topical composition for use in the treatment of inflammatory bowel disease |
MA45327A (en) | 2016-05-13 | 2019-03-20 | Sofar Spa | USE OF PROBIOTICS TO IMPROVE PROTEIN ABSORPTION |
MA45288A (en) | 2016-06-08 | 2019-04-17 | Sofar Spa | New medical use of probiotics |
IT201600122724A1 (en) | 2016-12-02 | 2018-06-02 | Sofar Spa | EXOPOLYSACCHARIDES AND USES THEREOF |
IT201600127498A1 (en) | 2016-12-16 | 2018-06-16 | Sofar Spa | PROBIOTICS FOR USE IN DIVERTICULOSIS AND DIVERTICULAR DISEASE |
WO2018135543A1 (en) * | 2017-01-19 | 2018-07-26 | 国立大学法人島根大学 | Diagnostic drug, diagnostic method and diagnostic device for permeability of intestinal mucosa |
US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5158940A (en) * | 1990-02-14 | 1992-10-27 | The United States Government As Represented By The Secretary, Dhhs | Use of suramin to treat rheumatologic diseases |
US5980865A (en) * | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
SE9602644D0 (en) * | 1996-07-04 | 1996-07-04 | Astra Ab | New use |
US6653294B2 (en) * | 2000-02-29 | 2003-11-25 | Food Industry Research & Development Institute | Use of chitinous materials for inhibiting cellular nitric oxide production |
-
2002
- 2002-04-24 WO PCT/IB2002/002275 patent/WO2003090763A1/en not_active Application Discontinuation
- 2002-04-24 AU AU2002309180A patent/AU2002309180A1/en not_active Abandoned
- 2002-04-24 CN CN02828982.XA patent/CN1627948A/en active Pending
- 2002-04-24 EP EP02735862A patent/EP1539192A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2003090763A1 (en) | 2003-11-06 |
EP1539192A1 (en) | 2005-06-15 |
CN1627948A (en) | 2005-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003034984A9 (en) | Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders | |
WO2003072035A8 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004041170A9 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2003259735A1 (en) | Small-mer compositions and methods of use | |
WO2004024097A9 (en) | Compositions and methods for the treatment of immune related diseases | |
EP1571968A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004016225A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004045516A9 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1592384A3 (en) | Cop 1 for treatment of inflammatory bowel diseases | |
EP1581119A4 (en) | Compositions and methods for the therapy and diagnosis of inflammatory bowel disease | |
HK1082256A1 (en) | New compounds, compositions and methods for treatment of inflammatory diseases and conditions | |
AU2003221745A1 (en) | rAAV VECTOR-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MAMMALIAN DISEASES | |
IL152127A0 (en) | Probiotic compositions for the treatment of inflammatory bowel disease | |
EP1572091A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004060270A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1711197A4 (en) | Methods and compositions for the prevention and treatment of inflammatory diseases or conditions | |
AU2003271944A1 (en) | Methods for making water treatment compositions and compositions thereof | |
WO2003057160A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003299441A1 (en) | Nf-hev compositions and methods of use | |
AU2003290605A1 (en) | Compositions and methods for the diagnosis and treatment of sepsis | |
AU2002233928A1 (en) | Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases | |
AU2002309180A1 (en) | Composition and kit for the treatment of inflammatory bowel diseases | |
IL155174A0 (en) | Methods and compositions for the treatment of inflammatory diseases | |
AU2003219160A1 (en) | Methods and compositions for the treatment of cancer | |
AU2003206945A1 (en) | Use of proteinase inhibitors in the treatment of autoimmune diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |